| Accession |
PRJCA025200 |
| Title |
A Phase 1 Clinical Study of GC012F Injection in Subjects with Relapsed/Refractory Multiple Myeloma |
| Relevance |
Medical |
| Data types |
clinical study
|
| Organisms |
Homo sapiens
|
| Description |
This is a single-arm, non-randomized, open-trial clinical study to evaluate the safety and efficacy of GC012F in patients with relapsed refractory multiple myeloma. 10 evaluable subjects were dosed. |
| Sample scope |
Multiisolate |
| Release date |
2024-04-11 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| No funding support
|
|
|
|
|
|
| Submitter |
siyu
huang (siyu.huang@gracellbio.com)
|
| Organization |
Gracell Biotechnologies (Shanghai) Co., Ltd. |
| Submission date |
2024-04-11 |
